4//SEC Filing
Horn Howard 4
Accession 0001209191-20-040660
CIK 0001706431other
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 6:42 PM ET
Size
10.2 KB
Accession
0001209191-20-040660
Insider Transaction Report
Form 4
Horn Howard
CFO
Transactions
- Sale
Common Stock
2020-07-01$37.72/sh−9,100$343,275→ 218,677 total - Sale
Common Stock
2020-07-01$39.33/sh−400$15,732→ 217,777 total - Sale
Common Stock
2020-07-01$38.78/sh−500$19,392→ 218,177 total - Sale
Common Stock
2020-07-02$40.00/sh−10,000$400,000→ 207,777 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.16 to $38.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F3]The price reported in Column 4 is a weighted average price and includes 200 shares sold at $38.19 and 300 shares sold at $39.18.
Documents
Issuer
Vir Biotechnology, Inc.
CIK 0001706431
Entity typeother
Related Parties
1- filerCIK 0001786335
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 6:42 PM ET
- Size
- 10.2 KB